Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine.
Vaccine. 2020 Apr 16;38(18):3489-3500. doi: 10.1016/j.vaccine.2019.11.058. Epub 2019 Dec 7.
Vaccine. 2020.
PMID: 31818534
Free article.
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
Pirrotta P, Tavares-Da-Silva F, Co M, Lecrenier N, Hervé C, Stegmann JU.
Pirrotta P, et al.
Drug Saf. 2021 Dec;44(12):1341-1353. doi: 10.1007/s40264-021-01118-3. Epub 2021 Oct 7.
Drug Saf. 2021.
PMID: 34622421
Free PMC article.
Review.
Item in Clipboard
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials.
Kim JH, Diaz-Decaro J, Jiang N, Hwang SJ, Choo EJ, Co M, Hastie A, Hui DSC, Irimajiri J, Lee J, Leung EM, Tang H, Tsuru T, Watson P, Wu Z, Yu CJ, Yuan Y, Zahaf T, Cunningham AL, Schuind A.
Kim JH, et al.
Hum Vaccin Immunother. 2021 Jul 3;17(7):2050-2057. doi: 10.1080/21645515.2020.1859321. Epub 2021 Feb 19.
Hum Vaccin Immunother. 2021.
PMID: 33606577
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.